OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE

por A. A. Kovaleva, A. A. Shaldzhyan, M. V. Zaitseva, L. A. Stepanova, L. M. Tsybalova
Publicado 2018

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine

por L. M. Tsybalova, L. A. Stepanova, A. V. Korotkov, M. A. Shuklina, M. V. Zaitseva, V. I. Grishchenko, R. Yu. Kotlyarov
Publicado 2019